focus -WSS

focus

author：fashion 2025-09-29 10:59:27 - browse：28

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Illumina board agrees to spin off Grail, as divestment plans proceed

WSS

STAT wants to know your pick for a great summer read or listen

ASCO Takeaways: Winners, snoozers, and the art of cancer care

The debate over Covid

An outdated Medicare rule harms dementia patients with anxiety

A Greenpeace activist is fined for crash

BD to buy Edwards patient monitoring unit for $4.2 billion

knowledge

focus

hotspot

Sports medicine is finally prioritizing gender equality

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

In age of alternative facts, a scholarly course on calling out crap

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eli Lilly’s Zepbound improved liver scarring in mid

Walensky prepares to leave CDC — and Congress — behind

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Malaria cases in Florida and Texas: Here’s what you need to know

For pregnant people, addiction treatment shouldn't mean a call to child protective services

leisure time

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Eli Lilly’s Zepbound improved liver scarring in mid

How CO2 helps viruses stay alive longer in the air

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

An outdated Medicare rule harms dementia patients with anxiety

hotspot

hotspot

entertainment

explore